Since the beginning of the coronavirus 2019 (COVID-19) pandemic, there has been enormous interest in understanding the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on people with HIV (PWH).
We used screening data and routine clinic records for intervention arm patients in the Simplified Algorithm for Treatment Eligibility (SLATE) trials to describe the prevalence of tuberculosis (TB) symptoms, diagnosis and treatment among people living with HIV (PLHIV), not on antiretroviral therapy (ART) and presenting at outpatient clinics in South Africa and Kenya. We compared the performance of the WHO four-symptom TB screening tool with a baseline Xpert test.
A study assessing changes in couples' sexual behaviors after HIV-negative partners discontinued pre-exposure prophylaxis (PrEP) and transitioned to rely primarily on their partner's adherence to antiretroviral therapy (ART) for prevention.
As the gap to reaching targets of controlling and eliminating the HIV pandemic closes, the difficulty to achieve them increases. Achieving aggressive treatment targets will require continued innovation of personalized and differentiated care models, and the proliferation data-driven approaches. USAID’s Data and Advanced Analytics in HIV Service Delivery: Use Cases to Help Reach 95-95-95 details high-priority advanced analytics use cases that could improve HIV service delivery globally.
An inclusive summit for multidisciplinary experts working with adolescents affected by HIV, which will be held as a series of virtual workshops throughout the month of November. Topics will include youth leadership, mental health and psychosocial support interventions, participatory research approaches, and Mhealth and new technologies, among others.
Some observational data suggest that the progestogen injectable contraceptive depot medroxyprogesterone acetate (DMPA) may increase a woman’s risk of HIV acquisition but a randomized clinical trial did not find a statistically significant incre